Assura PLC (LON:AGR)‘s stock had its “hold” rating reiterated by stock analysts at Peel Hunt in a note issued to investors on Tuesday. They currently have a GBX 55 ($0.69) price objective on the real estate investment trust’s stock. Peel Hunt’s target price suggests a potential downside of 7.64% from the stock’s previous close.

Separately, Liberum Capital reaffirmed a “hold” rating and set a GBX 60 ($0.75) price objective on shares of Assura PLC in a report on Monday, October 3rd.

Assura PLC (LON:AGR) opened at 59.964 on Tuesday. The firm’s 50-day moving average price is GBX 58.85 and its 200 day moving average price is GBX 57.61. Assura PLC has a 12 month low of GBX 48.08 and a 12 month high of GBX 61.00. The stock’s market cap is GBX 981.28 million.

About Assura PLC

Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company’s property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston.

Receive News & Stock Ratings for Assura PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura PLC and related stocks with our FREE daily email newsletter.